NIH Funding Mechanisms
Speaker: Vicky Whittemore, PhD
Institution: National Institute of Neurological Disorders and Stroke – NIH
Phenylbutyrate for STXBP1 and SLC6A1
Speaker: Zachary Grinspan, MD MS
Institution: Weill Cornell Medicine
4-phenylbutyrate rescue of SLC6A1 mutations in cell SLC6A1 mutation-mediated and mouse models disorders in patient derived cell and mouse models
Speaker: Jing-Qiong (Katty) Kang, MD, PhD
Institution: Vanderbilt University
Clinical Trial Readiness for SLC6A1-related neurodevelopmental disorder
Speaker: Kim Goodspeed, MD, MSCS
Institution: UT Southwestern Medical Center, CTSA Program
SLC6A1 Siblings
Speaker: Laura Bermingham